Trump announces trade deal with EU following months of negotiations
AstraZeneca PLC (LON:AZN) (LSE:AZN, STO:AZN, NASDAQ:AZN) announced Monday that its issued share capital with voting rights stands at 1,550,670,668 ordinary shares of $0.25 each as of June 30, 2025. The company confirmed that no shares are held in treasury, making the total number of voting rights in AstraZeneca (NASDAQ:AZN) equal to its issued share capital.
This figure was disclosed in accordance with the UK Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1. AstraZeneca stated that shareholders can use this number as the denominator for calculations related to notifications of interests or changes in interests under the relevant UK regulatory requirements.
The information is based on a press release statement included in the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.